Location History:
- Constance, DE (2013 - 2016)
- Konstanz, DE (2017)
Company Filing History:
Years Active: 2013-2017
Title: The Innovative Contributions of Clemens Braun
Introduction
Clemens Braun is a notable inventor based in Constance, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory pulmonary diseases. With a total of 4 patents to his name, Braun's work has had a considerable impact on medical research and development.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Combination of HMG-CoA reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases." This invention focuses on the combined use of a PDE4 inhibitor with a HMG-CoA reductase inhibitor to prevent and treat inflammatory pulmonary diseases effectively. Another notable patent is for "Pyrazolone-derivatives and their use as PDE-4 inhibitors," which introduces novel compounds that serve as effective inhibitors of type 4 phosphodiesterase.
Career Highlights
Clemens Braun has worked with prominent companies in the pharmaceutical industry, including Takeda GmbH and AstraZeneca AB. His experience in these organizations has allowed him to develop innovative solutions that address critical health issues.
Collaborations
Throughout his career, Braun has collaborated with esteemed colleagues such as Degenhard Marx and Dieter Flockerzi. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Clemens Braun's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving healthcare. His work continues to influence the treatment of inflammatory pulmonary diseases, showcasing the importance of innovation in medicine.